NEJM quality of care
This article was originally published in The Gray Sheet
Executive Summary
Editorial response by Earl Steinberg, MD/MPP, Johns Hopkins University, to June 26 1New England Journal of Medicine study on "The Quality of Care Delivered to Adults in the United States" questions findings of the survey - heralded as a "wake-up call" by AdvaMed. "It would not be appropriate to interpret this as showing that a typical adult in the U.S. has a 50-50 chance of receiving adequate care of a particular clinical condition," Steinberg says. The study, which found that respondents received 54.9% of recommended care based on 439 indicators for 30 acute and chronic conditions, was authored by Elizabeth McGlynn, PhD, RAND...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.